Melatonin as an Immunomodulator in Children with Down Syndrome

0
163
Scientists demonstrated that melatonin had several significant effects by reducing CD11b and TLR4 expression, attenuating TLR signaling, genes involved in the inflammasome and had the potential to reduce LPS-induced inflammatory responses.
[Pediatric Research]
Huggard, D., Kelly, L., Worrall, A., Gallagher, E., Fallah, L., Yoo, L. L., McGrane, F., Lagan, N., Roche, E., Balfe, J., Doherty, D. G., & Molloy, E. J. (2021). Melatonin as an immunomodulator in children with Down syndrome. Pediatric Research, 1–9. https://doi.org/10.1038/s41390-021-01611-6 Cite
Full Article